首页 > 最新文献

Lung India最新文献

英文 中文
Unveiling the Dark Area. 揭开黑暗区域的面纱
IF 1.3 Q4 RESPIRATORY SYSTEM Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.4103/lungindia.lungindia_279_24
Ancy Nisha Nesarajan, Abdul Majeed Arshad, Irfan Ismail Ayub, Dhanasekar Thangaswamy
{"title":"Unveiling the Dark Area.","authors":"Ancy Nisha Nesarajan, Abdul Majeed Arshad, Irfan Ismail Ayub, Dhanasekar Thangaswamy","doi":"10.4103/lungindia.lungindia_279_24","DOIUrl":"10.4103/lungindia.lungindia_279_24","url":null,"abstract":"","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"391-392"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472993/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of long-term inhaled corticosteroids therapy on cognitive function in patients with bronchial asthma and chronic obstructive pulmonary disease. 长期吸入皮质类固醇治疗对支气管哮喘和慢性阻塞性肺病患者认知功能的影响。
IF 1.3 Q4 RESPIRATORY SYSTEM Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.4103/lungindia.lungindia_399_23
Suikriti Sharma, Deepika Karki, Kanivi Julitta

Background: Inhaled corticosteroids (ICS) are prominent therapies for managing both asthma and chronic obstructive pulmonary disease (COPD). It has been noted that cognitive impairment is usually linked to high levels of corticosteroids in the blood.

Objective: This investigation aims to ascertain how long-term inhaled corticosteroid treatment affects individuals with bronchial asthma and COPD's cognitive performance.

Methodology: A total of 139 inpatients diagnosed with COPD and bronchial asthma were enrolled in the study of which 43 were newly diagnosed (group 1), 34 were taking ICS for 0.5-1 year (group 2) and 62 were on long-term ICS, that is, for >2 years (group 3). Patients with a score of at least 24 were considered to have normal cognitive function as prescribed by the Montreal Cognitive Assessment scale.

Result: It was observed that 56 patients (90.3%) were on long-term ICS treatment, 25 patients (73.5%) were on intermediate therapy and 27 patients (62.7%) who were newly diagnosed had cognitive impairment.

Conclusion: In conclusion, the duration of ICS therapy was significantly associated with a decline in cognitive function.

背景:吸入皮质类固醇(ICS)是治疗哮喘和慢性阻塞性肺病(COPD)的主要疗法。人们注意到,认知障碍通常与血液中皮质类固醇水平过高有关:本调查旨在确定长期吸入皮质类固醇治疗如何影响支气管哮喘和慢性阻塞性肺病患者的认知能力:共有 139 名确诊为慢性阻塞性肺病和支气管哮喘的住院患者参与了研究,其中 43 人是新确诊患者(第 1 组),34 人服用 ICS 0.5-1 年(第 2 组),62 人长期服用 ICS,即超过 2 年(第 3 组)。根据蒙特利尔认知评估量表的规定,得分不低于 24 分的患者被视为认知功能正常:结果:56 名患者(90.3%)接受了长期 ICS 治疗,25 名患者(73.5%)接受了中期治疗,27 名新确诊患者(62.7%)存在认知障碍:总之,ICS 治疗时间的长短与认知功能的下降有明显关系。
{"title":"Effect of long-term inhaled corticosteroids therapy on cognitive function in patients with bronchial asthma and chronic obstructive pulmonary disease.","authors":"Suikriti Sharma, Deepika Karki, Kanivi Julitta","doi":"10.4103/lungindia.lungindia_399_23","DOIUrl":"10.4103/lungindia.lungindia_399_23","url":null,"abstract":"<p><strong>Background: </strong>Inhaled corticosteroids (ICS) are prominent therapies for managing both asthma and chronic obstructive pulmonary disease (COPD). It has been noted that cognitive impairment is usually linked to high levels of corticosteroids in the blood.</p><p><strong>Objective: </strong>This investigation aims to ascertain how long-term inhaled corticosteroid treatment affects individuals with bronchial asthma and COPD's cognitive performance.</p><p><strong>Methodology: </strong>A total of 139 inpatients diagnosed with COPD and bronchial asthma were enrolled in the study of which 43 were newly diagnosed (group 1), 34 were taking ICS for 0.5-1 year (group 2) and 62 were on long-term ICS, that is, for >2 years (group 3). Patients with a score of at least 24 were considered to have normal cognitive function as prescribed by the Montreal Cognitive Assessment scale.</p><p><strong>Result: </strong>It was observed that 56 patients (90.3%) were on long-term ICS treatment, 25 patients (73.5%) were on intermediate therapy and 27 patients (62.7%) who were newly diagnosed had cognitive impairment.</p><p><strong>Conclusion: </strong>In conclusion, the duration of ICS therapy was significantly associated with a decline in cognitive function.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"357-361"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472989/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of obstructive airway disease in the multicenter SWORD survey India. 印度多中心 SWORD 调查对阻塞性气道疾病的评估。
IF 1.3 Q4 RESPIRATORY SYSTEM Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.4103/lungindia.lungindia_202_24
Sheetu Singh, Bharat Bhushan Sharma, Arvind Kumar Sharma, Nishtha Singh, Aradhana Singh, Krishna Kumar Sharma, Tariq Mahmood, Kumar Utsav Samaria, A Sundaramurthy, Surya Kant, Tejraj Singh, Parvaiz A Koul, Virendra Singh

Background and objectives: The study aimed to assess the control of asthma and the severity of chronic obstructive pulmonary disease (COPD) and evaluate the adequacy of treatment in patients presenting to the outpatient department (OPD) across India. The secondary aim was to assess the risk factors associated with poorly controlled asthma and severe COPD.

Materials and methods: This is the analysis of Phase IV of the multicenter questionnaire-based point prevalence SWORD survey, conducted in May 2018, and designed to capture details on disease control and treatment as per the global initiative for asthma and the global initiative for chronic obstructive lung disease guidelines.

Results: Of the 5,311 respiratory disease patients presenting to the OPD, there were 1,419 and 412 patients with asthma and COPD, respectively, across 290 sites in India. There were 1,022 (72%) patients having well-controlled asthma, 293 (20.6%) patients with partly controlled asthma, and 104 (7.4%) patients with poorly controlled asthma. Of the 412 patients with COPD, there were 307 (74.5%) in A, 54 (13.1%) in B, and 51 (12.4%) in the E category. In spite of poor control or severe disease, 34.8% of asthmatic and 25.7% of patients in the B and E categories of COPD were not using any medicine. Risk factors for partly and poorly controlled asthma included rain wetting (adjusted odds ratio [AOR]: 1.59, 95% confidence interval [CI]: 1.02-2.47) and gastroesophageal reflux disease (AOR: 1.50, 95%CI: 1.08-2.10).

Conclusion: This study identifies a gap in the treatment of both poorly controlled asthma and severe COPD. A substantial number of patients had poorly controlled asthma and severe COPD, and many were either not taking treatment or taking it inappropriately.

背景和目的:该研究旨在评估哮喘的控制情况和慢性阻塞性肺病(COPD)的严重程度,并评估印度各地门诊部(OPD)就诊患者的治疗是否充分。次要目的是评估与哮喘控制不佳和严重慢性阻塞性肺病相关的风险因素:这是 2018 年 5 月开展的基于多中心问卷的点流行率 SWORD 调查第四阶段的分析,旨在根据全球哮喘倡议和全球慢性阻塞性肺病倡议指南了解疾病控制和治疗的详细情况:在印度 290 个医疗点的 5311 名到门诊部就诊的呼吸系统疾病患者中,分别有 1419 名和 412 名哮喘和慢性阻塞性肺疾病患者。哮喘控制良好的患者有 1022 人(72%),哮喘部分控制的患者有 293 人(20.6%),哮喘控制不佳的患者有 104 人(7.4%)。在 412 名慢性阻塞性肺病患者中,有 307 人(74.5%)属于 A 类,54 人(13.1%)属于 B 类,51 人(12.4%)属于 E 类。尽管病情控制不佳或严重,但 34.8%的哮喘患者和 25.7%的 B 类及 E 类慢性阻塞性肺病患者没有使用任何药物。部分哮喘和哮喘控制不佳的风险因素包括雨天打湿(调整后的几率比[AOR]:1.59,95%置信区间[CI]:1.02-2.47)和胃食管反流病(AOR:1.50,95%置信区间[CI]:1.08-2.10):这项研究发现了在治疗控制不佳的哮喘和严重慢性阻塞性肺疾病方面存在的差距。大量患者的哮喘和严重慢性阻塞性肺疾病控制不佳,其中许多人要么没有接受治疗,要么治疗不当。
{"title":"Assessment of obstructive airway disease in the multicenter SWORD survey India.","authors":"Sheetu Singh, Bharat Bhushan Sharma, Arvind Kumar Sharma, Nishtha Singh, Aradhana Singh, Krishna Kumar Sharma, Tariq Mahmood, Kumar Utsav Samaria, A Sundaramurthy, Surya Kant, Tejraj Singh, Parvaiz A Koul, Virendra Singh","doi":"10.4103/lungindia.lungindia_202_24","DOIUrl":"10.4103/lungindia.lungindia_202_24","url":null,"abstract":"<p><strong>Background and objectives: </strong>The study aimed to assess the control of asthma and the severity of chronic obstructive pulmonary disease (COPD) and evaluate the adequacy of treatment in patients presenting to the outpatient department (OPD) across India. The secondary aim was to assess the risk factors associated with poorly controlled asthma and severe COPD.</p><p><strong>Materials and methods: </strong>This is the analysis of Phase IV of the multicenter questionnaire-based point prevalence SWORD survey, conducted in May 2018, and designed to capture details on disease control and treatment as per the global initiative for asthma and the global initiative for chronic obstructive lung disease guidelines.</p><p><strong>Results: </strong>Of the 5,311 respiratory disease patients presenting to the OPD, there were 1,419 and 412 patients with asthma and COPD, respectively, across 290 sites in India. There were 1,022 (72%) patients having well-controlled asthma, 293 (20.6%) patients with partly controlled asthma, and 104 (7.4%) patients with poorly controlled asthma. Of the 412 patients with COPD, there were 307 (74.5%) in A, 54 (13.1%) in B, and 51 (12.4%) in the E category. In spite of poor control or severe disease, 34.8% of asthmatic and 25.7% of patients in the B and E categories of COPD were not using any medicine. Risk factors for partly and poorly controlled asthma included rain wetting (adjusted odds ratio [AOR]: 1.59, 95% confidence interval [CI]: 1.02-2.47) and gastroesophageal reflux disease (AOR: 1.50, 95%CI: 1.08-2.10).</p><p><strong>Conclusion: </strong>This study identifies a gap in the treatment of both poorly controlled asthma and severe COPD. A substantial number of patients had poorly controlled asthma and severe COPD, and many were either not taking treatment or taking it inappropriately.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"335-344"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11473000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"The hidden impact": Traumatic pseudocyst of the lung. "隐藏的影响创伤性肺伪囊肿
IF 1.3 Q4 RESPIRATORY SYSTEM Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.4103/lungindia.lungindia_90_24
Manish Singh, V Shrinath, Deepu Peter, Ankit Mathur
{"title":"\"The hidden impact\": Traumatic pseudocyst of the lung.","authors":"Manish Singh, V Shrinath, Deepu Peter, Ankit Mathur","doi":"10.4103/lungindia.lungindia_90_24","DOIUrl":"10.4103/lungindia.lungindia_90_24","url":null,"abstract":"","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"397-399"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472987/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Managing risk of infectious disease transmission at religious mass gatherings. 管理宗教群众集会中的传染病传播风险。
IF 1.3 Q4 RESPIRATORY SYSTEM Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.4103/lungindia.lungindia_234_24
Hineptch Daungsupawong, Viroj Wiwanitkit
{"title":"Managing risk of infectious disease transmission at religious mass gatherings.","authors":"Hineptch Daungsupawong, Viroj Wiwanitkit","doi":"10.4103/lungindia.lungindia_234_24","DOIUrl":"10.4103/lungindia.lungindia_234_24","url":null,"abstract":"","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"400"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stockout of anti-TB drugs: Are we going to lose the gains achieved in year 2022-2023? 抗结核药物库存短缺:我们会失去 2022-2023 年取得的成果吗?
IF 1.3 Q4 RESPIRATORY SYSTEM Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.4103/lungindia.lungindia_181_24
Nitin Jain, Manisha Jain, Ashutosh Chaturvedi, Nirmal K Jain
{"title":"Stockout of anti-TB drugs: Are we going to lose the gains achieved in year 2022-2023?","authors":"Nitin Jain, Manisha Jain, Ashutosh Chaturvedi, Nirmal K Jain","doi":"10.4103/lungindia.lungindia_181_24","DOIUrl":"10.4103/lungindia.lungindia_181_24","url":null,"abstract":"","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"333-334"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of unusually long apnoea in a young man with obstructive sleep apnoea. 一例患有阻塞性睡眠呼吸暂停的年轻男子出现异常长时间的呼吸暂停。
IF 1.3 Q4 RESPIRATORY SYSTEM Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.4103/lungindia.lungindia_581_23
Kirti Kadian, Alkesh Kumar Khurana, Abhishek Goyal, Prakhar Agarwal
{"title":"A case of unusually long apnoea in a young man with obstructive sleep apnoea.","authors":"Kirti Kadian, Alkesh Kumar Khurana, Abhishek Goyal, Prakhar Agarwal","doi":"10.4103/lungindia.lungindia_581_23","DOIUrl":"10.4103/lungindia.lungindia_581_23","url":null,"abstract":"","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"381-382"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472995/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anaesthetic challenges of carinal resection and reconstruction: A case report. 椎动脉切除和重建的麻醉挑战:病例报告
IF 1.3 Q4 RESPIRATORY SYSTEM Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.4103/lungindia.lungindia_154_24
Ganapathy Arumugam C, Kavitha Sekar, R Sridhar, Ajay Narasimhan, R Narasimhan

Abstract: Carinal resection of tumour involving trachea and carina remains as a challenge for thoracic surgeons and anaesthesiologists. Resection is technically demanding and can be associated with significant morbidity and mortality. In this case report, we describe the successful management of carinal tumour with carinal resection in a 45-year-old female. The tumour was involving lowermost trachea, carina and bilateral primary bronchi causing 60% narrowing of the lower trachea just before carina, more than 90% narrowing of right main bronchus and 50% luminal narrowing of left main bronchus. Carinal resection and reconstruction were successfully performed under general anaesthesia. Patient was managed with conventional orotracheal intubation with Micro laryngeal endotracheal tube and positioned in left principal bronchus railroaded over a paediatric bronchoscope for lung isolation. After thoracotomy, the left main bronchus was intubated directly across the operative field with a sterile flexometallic endotracheal tube. With intermittent ventilation, anastomosis was completed. During anastomosis Micro laryngeal endotracheal tube cuff was damaged twice and we had to reintubate the patient twice in lateral position itself. At the end of anastomoses, flexometallic tube was removed and wound repaired. After confirming no leakage at anastomotic site, Micro laryngeal endotracheal tube was removed and Laryngeal Mask Airway was inserted and bronchial toileting done with adult bronchoscope. Meticulous planning and communication between the anaesthesia and surgical teams are mandatory for the safe and successful anaesthetic management of carinal resection surgeries.

摘要:对胸外科医生和麻醉师来说,气管和心管肿瘤的椎管切除术仍然是一项挑战。切除术对技术要求很高,可能会导致严重的发病率和死亡率。在本病例报告中,我们描述了一名 45 岁女性成功切除气管和心窝肿瘤的案例。肿瘤累及气管最下端、会厌和双侧主支气管,导致会厌前气管下端狭窄 60%,右主支气管狭窄 90%以上,左主支气管管腔狭窄 50%。在全身麻醉下,成功进行了气管切口切除和重建手术。对患者进行了常规气管插管,使用微型喉气管插管,并在小儿支气管镜上定位左主支气管,进行肺隔离。开胸手术后,用无菌挠性金属气管导管直接在手术区域内对左主支气管进行插管。在间歇通气的情况下,完成了吻合术。在吻合过程中,微喉气管导管袖带两次受损,我们不得不在侧卧位为患者重新插管两次。吻合结束后,我们拔出了柔性金属管并修复了伤口。在确认吻合部位无渗漏后,拔出了微喉气管导管,插入了喉罩气道,并用成人支气管镜进行了支气管通气。麻醉团队和手术团队之间的周密计划和沟通对于安全、成功地进行龋齿切除手术的麻醉管理至关重要。
{"title":"Anaesthetic challenges of carinal resection and reconstruction: A case report.","authors":"Ganapathy Arumugam C, Kavitha Sekar, R Sridhar, Ajay Narasimhan, R Narasimhan","doi":"10.4103/lungindia.lungindia_154_24","DOIUrl":"10.4103/lungindia.lungindia_154_24","url":null,"abstract":"<p><strong>Abstract: </strong>Carinal resection of tumour involving trachea and carina remains as a challenge for thoracic surgeons and anaesthesiologists. Resection is technically demanding and can be associated with significant morbidity and mortality. In this case report, we describe the successful management of carinal tumour with carinal resection in a 45-year-old female. The tumour was involving lowermost trachea, carina and bilateral primary bronchi causing 60% narrowing of the lower trachea just before carina, more than 90% narrowing of right main bronchus and 50% luminal narrowing of left main bronchus. Carinal resection and reconstruction were successfully performed under general anaesthesia. Patient was managed with conventional orotracheal intubation with Micro laryngeal endotracheal tube and positioned in left principal bronchus railroaded over a paediatric bronchoscope for lung isolation. After thoracotomy, the left main bronchus was intubated directly across the operative field with a sterile flexometallic endotracheal tube. With intermittent ventilation, anastomosis was completed. During anastomosis Micro laryngeal endotracheal tube cuff was damaged twice and we had to reintubate the patient twice in lateral position itself. At the end of anastomoses, flexometallic tube was removed and wound repaired. After confirming no leakage at anastomotic site, Micro laryngeal endotracheal tube was removed and Laryngeal Mask Airway was inserted and bronchial toileting done with adult bronchoscope. Meticulous planning and communication between the anaesthesia and surgical teams are mandatory for the safe and successful anaesthetic management of carinal resection surgeries.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"371-374"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472991/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Normative values of oxygen saturation by pulse oximetry (SpO2) in apparently healthy children from Eastern India - A cross-sectional study. 印度东部表面健康儿童脉搏血氧饱和度 (SpO2) 的正常值 - 一项横断面研究。
IF 1.3 Q4 RESPIRATORY SYSTEM Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.4103/lungindia.lungindia_485_23
Vivekan R Chada, Krishna M Gulla, Rashmi R Das, Ketan Kumar

Objectives: The primary objective was to determine normative values of oxygen saturation (SpO2) by pulse oximetry in apparently healthy children, aged 1 month to 14 years. The secondary objective was to explore any variation in oxygen saturation levels by age and gender.

Materials and methods: It was a cross-sectional study conducted at a tertiary care centre and schools in Bhubaneswar, Odisha, India, from January 2021 to December 2022. Apparently healthy children were enrolled. Using a standardized pulse oximeter and appropriately sized probes, SpO2 was recorded after stabilization of plethysmograph waves. Three consecutive readings were taken, and an average was noted. The 2.5th centile SpO2 value was taken as the lower limit of normal.

Results: The median (IQR) saturation of the sample population was 99.7% (99-100). The 2.5th, 5th, 25th, and 75th percentiles were 97.7%, 98%, 99%, and 100%, respectively. Median SpO2 and its percentiles were estimated for each age group. The 2.5th centile SpO2 for infantile age group was 96.4%. No significant age and gender-wise variations of SpO2 were noted.

Conclusions: The present study established normal reference range oxygen SpO2 levels in apparently healthy children from an eastern India region that is situated at 62 m (204 ft) above the sea level.

目标:主要目的是通过脉搏血氧仪确定 1 个月至 14 岁表面健康儿童的血氧饱和度 (SpO2) 标准值。次要目的是探索氧饱和度水平在年龄和性别上的差异:这是一项横断面研究,于 2021 年 1 月至 2022 年 12 月在印度奥迪沙邦布巴内斯瓦尔的一家三级护理中心和学校进行。研究对象为表面健康的儿童。使用标准脉搏血氧仪和适当大小的探头,在胸透波稳定后记录 SpO2。连续读取三个读数并记录平均值。以 SpO2 值的 2.5 百分位数作为正常值的下限:结果:样本人群的饱和度中位数(IQR)为 99.7%(99-100)。2.5、5、25 和 75 百分位数分别为 97.7%、98%、99% 和 100%。对每个年龄组的 SpO2 中位数及其百分位数进行了估算。婴儿组的 2.5 百分位数 SpO2 为 96.4%。SpO2的年龄和性别差异不大:本研究确定了印度东部海拔 62 米(204 英尺)地区明显健康儿童的正常参考范围氧 SpO2 水平。
{"title":"Normative values of oxygen saturation by pulse oximetry (SpO2) in apparently healthy children from Eastern India - A cross-sectional study.","authors":"Vivekan R Chada, Krishna M Gulla, Rashmi R Das, Ketan Kumar","doi":"10.4103/lungindia.lungindia_485_23","DOIUrl":"10.4103/lungindia.lungindia_485_23","url":null,"abstract":"<p><strong>Objectives: </strong>The primary objective was to determine normative values of oxygen saturation (SpO2) by pulse oximetry in apparently healthy children, aged 1 month to 14 years. The secondary objective was to explore any variation in oxygen saturation levels by age and gender.</p><p><strong>Materials and methods: </strong>It was a cross-sectional study conducted at a tertiary care centre and schools in Bhubaneswar, Odisha, India, from January 2021 to December 2022. Apparently healthy children were enrolled. Using a standardized pulse oximeter and appropriately sized probes, SpO2 was recorded after stabilization of plethysmograph waves. Three consecutive readings were taken, and an average was noted. The 2.5th centile SpO2 value was taken as the lower limit of normal.</p><p><strong>Results: </strong>The median (IQR) saturation of the sample population was 99.7% (99-100). The 2.5th, 5th, 25th, and 75th percentiles were 97.7%, 98%, 99%, and 100%, respectively. Median SpO2 and its percentiles were estimated for each age group. The 2.5th centile SpO2 for infantile age group was 96.4%. No significant age and gender-wise variations of SpO2 were noted.</p><p><strong>Conclusions: </strong>The present study established normal reference range oxygen SpO2 levels in apparently healthy children from an eastern India region that is situated at 62 m (204 ft) above the sea level.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"362-365"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472994/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The minimal important difference of one-minute-sit-to-stand test in subjects with chronic pulmonary aspergillosis. 慢性肺曲霉菌病患者一分钟坐立测试的最小重要差异。
IF 1.3 Q4 RESPIRATORY SYSTEM Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.4103/lungindia.lungindia_168_24
Inderpaul Singh Sehgal, Sahajal Dhooria, Valliappan Muthu, Kuruswamy Thurai Prasad, Kathirvel Soundappan, Ashutosh Nath Aggarwal, Arunaloke Chakrabarti, Shivaprakash Mandya Rudramurthy, Ritesh Agarwal

Background and objective: There is a need for simple functional test to assess treatment response in chronic pulmonary aspergillosis (CPA) in resource-constrained settings. The one-minute-sit-to-stand test (1-min-STS) is one such test. However, the minimal important difference (MID) for 1-min-STS in subjects with CPA remains unknown. Herein, we estimate the MID for 1-min-STS for CPA subjects.

Materials and methods: We retrospectively reviewed the clinical details of CPA subjects treated with oral azoles for 6 months. We included only subjects who completed the 1-min-STS test at baseline and 6 months. We used the change in VAS (visual analogue scale, for overall improvement) as an external anchor. We used the anchor and the distribution (standard deviation-based) methods to determine the MID estimates. We used the anchor-based method only if there was correlation of 0.3 with the 1-min-STS test.

Results: One hundred-eight subjects completed the 1-min-STS test at baseline and 6 months. We did not find significant correlation between the change in VAS for overall improvement (r2 = 0.024, P value = 0.809) and the 1-min-STS test. The MID for the 1-min-STS test was 2 repetitions (range, 1.5-2.8 repetitions).

Conclusion: The MID for the 1-min-STS test in subjects with CPA was 2 repetitions. Future studies using a global rating of change scale as an anchor must confirm our findings.

背景和目的:在资源有限的情况下,需要简单的功能测试来评估慢性肺曲霉菌病(CPA)的治疗反应。一分钟坐立测试(1-min-STS)就是这样一种测试。然而,1-min-STS 在 CPA 患者中的最小重要差异(MID)仍然未知。在此,我们估算了 CPA 受试者 1 分钟坐立测试的最小重要差异:我们回顾性审查了接受口服唑类药物治疗 6 个月的 CPA 受试者的临床详情。我们只纳入了在基线和 6 个月时完成 1 分钟-STS 测试的受试者。我们将 VAS(视觉模拟量表,表示总体改善情况)的变化作为外部锚点。我们使用锚定法和分布法(基于标准差)来确定 MID 估计值。只有当与 1 分钟-STS 测试的相关性达到 0.3 时,我们才使用基于锚的方法:118 名受试者在基线和 6 个月时完成了 1 分钟-STS 测试。我们没有发现整体改善的 VAS 变化(r2 = 0.024,P 值 = 0.809)与 1 分钟-STS 测试之间存在明显的相关性。1分钟-STS测试的中位数为2次(范围为1.5-2.8次):结论:在 CPA 患者中,1 分钟-STS 测试的中位数为重复 2 次。结论:CPA 患者的 1 分钟-STS 测试中位数为重复 2 次。未来的研究必须使用全球变化评分量表作为锚,以证实我们的研究结果。
{"title":"The minimal important difference of one-minute-sit-to-stand test in subjects with chronic pulmonary aspergillosis.","authors":"Inderpaul Singh Sehgal, Sahajal Dhooria, Valliappan Muthu, Kuruswamy Thurai Prasad, Kathirvel Soundappan, Ashutosh Nath Aggarwal, Arunaloke Chakrabarti, Shivaprakash Mandya Rudramurthy, Ritesh Agarwal","doi":"10.4103/lungindia.lungindia_168_24","DOIUrl":"10.4103/lungindia.lungindia_168_24","url":null,"abstract":"<p><strong>Background and objective: </strong>There is a need for simple functional test to assess treatment response in chronic pulmonary aspergillosis (CPA) in resource-constrained settings. The one-minute-sit-to-stand test (1-min-STS) is one such test. However, the minimal important difference (MID) for 1-min-STS in subjects with CPA remains unknown. Herein, we estimate the MID for 1-min-STS for CPA subjects.</p><p><strong>Materials and methods: </strong>We retrospectively reviewed the clinical details of CPA subjects treated with oral azoles for 6 months. We included only subjects who completed the 1-min-STS test at baseline and 6 months. We used the change in VAS (visual analogue scale, for overall improvement) as an external anchor. We used the anchor and the distribution (standard deviation-based) methods to determine the MID estimates. We used the anchor-based method only if there was correlation of 0.3 with the 1-min-STS test.</p><p><strong>Results: </strong>One hundred-eight subjects completed the 1-min-STS test at baseline and 6 months. We did not find significant correlation between the change in VAS for overall improvement (r2 = 0.024, P value = 0.809) and the 1-min-STS test. The MID for the 1-min-STS test was 2 repetitions (range, 1.5-2.8 repetitions).</p><p><strong>Conclusion: </strong>The MID for the 1-min-STS test in subjects with CPA was 2 repetitions. Future studies using a global rating of change scale as an anchor must confirm our findings.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 5","pages":"353-356"},"PeriodicalIF":1.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472996/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Lung India
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1